Drug Topics
MAY 17, 2024
While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.
Pharmacy Times
MAY 17, 2024
Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 17, 2024
Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.
Pharmacy Times
MAY 17, 2024
Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MAY 17, 2024
The panel that worked on the report was made up of Big Tech players like Amazon, Google and Microsoft, as well as leaders such as Harvard Medical School, the Leapfrog Group and Kaiser Permanente.
Pharmacy Times
MAY 17, 2024
Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MAY 17, 2024
Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.
STAT
MAY 17, 2024
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down. But HIV scientists are nothing if not resilient, and used to trying one new approach after another.
Drug Topics
MAY 17, 2024
Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro Woolley, Washington, discussed the state of today’s independent pharmacy market, as well as his own pharmacy operations.
STAT
MAY 17, 2024
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived at a point where they could read, write, and edit any sequence of DNA. But composing whole genes or even whole genomes from scratch — that was something only evolution could do. A few years later, not long after helping to launch the Arc Institute, a nonprofit research center in the Bay Area, molecular engineer Patrick Hsu wondered if it was possible to imitate the forces of evolution
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 17, 2024
Inequities in mental health across the U.S. | ED overutilization, exacerbated comorbidities and lost productivity will drive trillions in "avoidable and unnecessary expenses" should inequities in mental health access and outcomes remain unchecked.
STAT
MAY 17, 2024
When Black people receive maternal care, they are often not treated the same as white people. In 2016, when Simmone Taitt had her first pregnancy loss, she was very well insured, had a high-paying job as a tech executive, and had access to one of the top OB-GYNs in New York City. Yet, when she found out that her baby had no heartbeat, she left that appointment with no medical follow-up, and no emotional or mental health support.
Fierce Healthcare
MAY 17, 2024
One in 4 adults in the U.S. | Challenges to inclusive design often stem from viewing disability as a binary status. However, disabilities vary widely in severity and permanency, with symptoms existing on a spectrum.
STAT
MAY 17, 2024
Extreme weather fueled by accelerating climate change puts patients, providers, and health care facilities at severe risk, jeopardizing lives. Unpredictable shifts in weather patterns are creating new regional extremes , and communities have to adjust to survive. During climate crises, health care providers and facilities must be ready to quickly adapt to shifting needs.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MAY 17, 2024
As summer approaches, remind patients to go back to basics with sunscreen and self-examinations.
STAT
MAY 17, 2024
Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco. “Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five mi
Pharmafile
MAY 17, 2024
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.
STAT
MAY 17, 2024
LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies. But to John-Arne Røttingen, the new head of the Wellcome Trust , one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.
Fierce Pharma
MAY 17, 2024
After Moderna last year suffered a loss in its heated patent fight against Pfizer and BioNTech, the mRNA drugmaker can now celebrate a win. | The win comes after a prior decision from the European Patent Office that invalidated Moderna's other asserted patent.
pharmaphorum
MAY 17, 2024
Brainomix gets FDA approval for e-Lung, an AI tool that assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.
STAT
MAY 17, 2024
SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health. “They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said.
Pharmacy Times
MAY 17, 2024
Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.
The Checkup by Singlecare
MAY 17, 2024
Every year, 1 in 6 Americans gets a foodborne illness from eating contaminated food or drinks. One kind of foodborne illness is food poisoning, caused by pathogens like bacteria, viruses, and other microbes. Food poisoning occurs when food is not properly stored, handled, or cooked, causing symptoms like stomach cramps, diarrhea, nausea, and vomiting.
Fierce Pharma
MAY 17, 2024
Following a controversy over Covis’ preterm birth drug Makena in the U.S. last year, the European Medicines Agency (EMA) is cracking down on hydroxyprogesterone caproate therapies across the pond. | A committee of the European Medicines Agency on Friday called for the withdrawal of preterm birth drugs containing 17-hydroxyprogesterone caproate (17-OHPC), citing safety and efficacy concerns.
pharmaphorum
MAY 17, 2024
Explore sustainable catalysis and its potential to transform chemical reactions in drug discovery. Learn how green chemistry plays a pivotal role in shaping the future of catalysis.
Fierce Pharma
MAY 17, 2024
Seven months after Amgen’s chief medical officer referred to trial | Seven months after Amgen’s chief medical officer referred to trial results for the company's investigational lung cancer immunotherapy as a “watershed moment,” the FDA has signed off on Imdelltra (tarlatamab) to treat patients with extensive-stage small-cell lung cancer (ES-SCLC).
The Checkup by Singlecare
MAY 17, 2024
Enbrel (etanercept), is a brand-name biologic drug that blocks the activity of tumor necrosis factor (TNF) , a substance in the body that can cause inflammation and lead to immune system diseases. It is taken as an injection under the skin once or twice a week as prescribed by a healthcare provider to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, and plaque psoriasis.
European Pharmaceutical Review
MAY 17, 2024
The US Food and Drug Administration (FDA) has approved Amgen’s Imdelltra (tarlatamab-dlle), a bispecific T-cell engager, for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC). The drug received accelerated regulatory approval based on the “encouraging response rate and duration of response (DoR) observed in clinical studies,” Amgen said.
STAT
MAY 17, 2024
As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart drug, CEO Robert Blum maintains that the biotech can launch the treatment — what would be its first approved medication — on its own. Cytokinetics reported top-line results of its drug, aficamten, in obstructive hypertrophic cardiomyopathy, or oHCM, last December, sending its shares up on speculation the company would get acquired.
European Pharmaceutical Review
MAY 17, 2024
Everything in the pharmaceutical industry now seems to rely increasingly heavily on effective organisation and handling of data. But what needs to happen so that users/process owners can fully trust data’s quality, integrity, reliability, etc? Steve Gens (SG): The more critical data becomes to regulatory procedures, to safety processes, to clinical research, to manufacturing, and ultimately connecting all of those parts of the value chain more seamlessly, the greater the need for formal and cons
Pharmaceutical Technology
MAY 17, 2024
The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and Wegovy.
European Pharmaceutical Review
MAY 17, 2024
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the suspension of the marketing authorisations for medicines containing 17-hydroxyprogesterone caproate (17-OHPC) in the European Union. The recommendation follows a review by the PRAC , which concluded that there is a “possible but unconfirmed risk of cancer in people exposed to 17-OHPC in the womb.
pharmaphorum
MAY 17, 2024
Navigating maternal vaccine trials: addressing safety, efficacy, and preterm birth risks. Insights on vaccines for pregnant women and maternal health.
STAT
MAY 17, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, take in a moving picture, and hold another listening party, where the rotation will likely include this , this , this , this and this.
Expert insights. Personalized for you.
247 
Let's personalize your content